Cowen Assumes Exagen (XGN) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts XGN Hot Sheet
Price: $8.59 -1.26%
Rating Summary:
9 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
9 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Cowen analyst Max Masucci assumes coverage on Exagen (NASDAQ: XGN) with a Outperform rating and a price target of $26.00.
For an analyst ratings summary and ratings history on Exagen click here. For more ratings news on Exagen click here.
Shares of Exagen closed at $12.71 yesterday.
You May Also Be Interested In
- Exagen Inc. to Participate in Upcoming Investor Conferences
- Morgan Stanley Assumes Clarivate Plc (CLVT) at Underweight
- Exagen to Announce Third Quarter Financial Results on November 10, 2026
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
